NATCOPHARMPharmaceuticals
Natco Pharma Ltd — Quarterly Results & Earnings
₹974.20
+0.51%
Profit Growth YoY-23.46%Latest quarter
Sales Growth YoY-0.59%Latest quarter
Sales CAGR 5Y18.26%5 year compound
Profit CAGR 5Y33.27%5 year compound
📋
Quarterly Performance
YoY Profit Growth-23.46%
🔴 Significant decline
YoY Sales Growth-0.59%
⚠️ Mild contraction
OPM 5Y Average
38.03%Operating profit margin
EPS Growth 5Y
33.70%Interest Coverage
61.04Higher = safer debt servicing
ROE
28.00%ROCE
32.78%💡
Growth Analysis
Natco Pharma Ltd reported YoY profit growth of -23.46% and revenue growth of -0.59% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at 18.26% and profits at 33.27% annually. This is above-average growth for Indian listed companies. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.
More on Natco Pharma Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.